Ligand Pharma (LGND) Tops Q2 EPS by 141c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $294.60 --0%
Financial Fact:
Gain on sale of a product line: 0
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Gain on sale of a product line: 0
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $1.81, $1.41 better than the analyst estimate of $0.40. Revenue for the quarter came in at $18.42 million versus the consensus estimate of $17 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- S&P 500 eyes record as retail slump, Iran risk set up pivotal week
- Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
